Your browser doesn't support javascript.
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals.
Faustini, Sian; Shields, Adrian; Banham, Gemma; Wall, Nadezhda; Al-Taei, Saly; Tanner, Chloe; Ahmed, Zahra; Efstathiou, Elena; Townsend, Neal; Goodall, Margaret; Plant, Tim; Perez-Toledo, Marisol; Jasiulewicz, Aleksandra; Price, Ruth; McLaughlin, James; Farnan, John; Moore, Julie; Robertson, Louise; Nesbit, Andrew; Curry, Grace; Black, Amy; Cunningham, Adam; Harper, Lorraine; Moore, Tara; Drayson, Mark; Richter, Alex.
  • Faustini S; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: s.e.faustini@bham.ac.uk.
  • Shields A; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; University Hospitals Birmingham National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom. Electronic address: a.m.shields@bham.ac.uk.
  • Banham G; Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; University Hospitals Birmingham National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom. Electronic address: emma.banham@nhs.net.
  • Wall N; Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; University Hospitals Birmingham National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom. Electronic address: nadya.wall@nhs.net.
  • Al-Taei S; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: s.al-taei@bham.ac.uk.
  • Tanner C; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: c.l.tanner@bham.ac.uk.
  • Ahmed Z; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: a.zahra@bham.ac.uk.
  • Efstathiou E; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: e.efstathiou@bham.ac.uk.
  • Townsend N; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: n.j.townsend@bham.ac.uk.
  • Goodall M; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: dm.goodall@bham.ac.uk.
  • Plant T; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: tplant.1@bham.ac.uk.
  • Perez-Toledo M; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: m.perez-toledo@bham.ac.uk.
  • Jasiulewicz A; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: a.jasiulewicz@bham.ac.uk.
  • Price R; Biomedical Sciences Research Institute, Ulster University, Northern Ireland. Electronic address: rk.price@ulster.ac.uk.
  • McLaughlin J; Nanotechnology and Integrated Bioengineering Centre, Ulster University, Northern Ireland. Electronic address: jad.mclaughlin@ulster.ac.uk.
  • Farnan J; The Group Surgery, 257 North Queen Street, Belfast, Northern, Ireland. Electronic address: john.farnan@doctors.org.uk.
  • Moore J; Biomedical Sciences Research Institute, Ulster University, Northern Ireland. Electronic address: Moore-J66@ulster.ac.uk.
  • Robertson L; Biomedical Sciences Research Institute, Ulster University, Northern Ireland. Electronic address: lrobertson@ulster.ac.uk.
  • Nesbit A; Biomedical Sciences Research Institute, Ulster University, Northern Ireland. Electronic address: a.nesbit@ulster.ac.uk.
  • Curry G; Biomedical Sciences Research Institute, Ulster University, Northern Ireland. Electronic address: G.Curry@ulster.ac.uk.
  • Black A; The Group Surgery, 257 North Queen Street, Belfast, Northern, Ireland. Electronic address: AmyBlack@doctors.org.uk.
  • Cunningham A; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: a.f.cunningham@bham.ac.uk.
  • Harper L; University Hospitals Birmingham National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom; Institute of Applied Health, University of Birmingham, Birmingham, United Kingdom. Electronic address: lharper@bham.ac.uk.
  • Moore T; Biomedical Sciences Research Institute, Ulster University, Northern Ireland; Nanotechnology and Integrated Bioengineering Centre, Ulster University, Northern Ireland; Avellino labs USA 1505 Adams Drive Menlo Park, CA 94025 USA. Electronic address: tara.moore@ulster.ac.uk.
  • Drayson M; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. Electronic address: m.t.drayson@bham.ac.uk.
  • Richter A; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; University Hospitals Birmingham National Health Service (NHS) Foundation Trust, Birmingham, United Kingdom. Electronic address: a.g.richter@bham.ac.uk.
J Infect ; 84(4): 579-613, 2022 04.
Article in English | MEDLINE | ID: covidwho-1706805
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article